Esperion Therapeutics Inc.

NAS: ESPR

GO
/marketstate/country/us

Market open

/zigman2/quotes/207049816/composite

$

6.77

Change

+0.22 +3.28%

Volume

Volume 337,845

Oct 4, 2022, 12:17 p.m.

Real time quotes

/zigman2/quotes/207049816/composite

Previous close

$ 6.55

$ 6.77

Change

+0.22 +3.28%

Day low

Day high

$6.56

$6.87

Open
Open: 6.57

52 week low

52 week high

$3.28

$11.91

Open

Market cap

$435.91M

Average volume

1.14M

P/E ratio

N/A

Rev. per Employee

$309,573

EPS

-6.37

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/espr

MarketWatch News on ESPR

  1. Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan

    8:29 a.m. May 5, 2022

    - Tomi Kilgore

  2. Esperion Therapeutics stock price target cut to $6 vs. $10 at JPMorgan

    8:42 a.m. Dec. 23, 2021

    - Ciara Linnane

  3. Esperion Therapeutics to reduce workforce by 40%

    7:59 a.m. Oct. 18, 2021

    - Jaimy Lee

  4. Esperion Therapeutics downgraded to hold from buy at Stifel Nicolaus

    7:44 a.m. May 5, 2021

    - Tomi Kilgore

  5. Esperion Therapeutics downgraded to neutral from buy at BofA Securities

    11:31 a.m. Jan. 15, 2021

    - Tomi Kilgore

  6. Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan

    8:17 a.m. March 13, 2019

    - Tomi Kilgore

  7. Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan

    8:15 a.m. March 13, 2019

    - Tomi Kilgore

  8. Esperion Therapeutics initiated at sell buy Goldman Sachs

    9:25 a.m. Dec. 13, 2018

    - Emily Bary

  9. Esperion Therapeutics price target lifted to $104 from $89 at Stifel

    9:32 a.m. Dec. 10, 2018

    - Tonya Garcia

  10. Esperion shares resume trading after halt up 1.9%

    7:32 a.m. Aug. 27, 2018

    - Ciara Linnane

  11. Esperion Therapeutics announces positive results in late-stage trial of ASCVD treatment

    7:03 a.m. Aug. 27, 2018

    - Ciara Linnane

  12. Esperion Therapeutics stock halted for news pending

    6:58 a.m. Aug. 27, 2018

    - Ciara Linnane

  13. Esperion’s Top Holder Buys $5.2 Million More in Stock

    11:26 a.m. May 23, 2018

    - Barrons Blogs

  14. Esperion shares halted on late-stage trial results

    8:39 a.m. May 23, 2018

    - Emma Court

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/espr

Other News on ESPR

  1. Esperion Therapeutics (ESPR) Investor Presentation - Slideshow

    1:33 p.m. Sept. 15, 2022

    - Seeking Alpha

  2. Esperion (ESPR) Q2 Earnings and Revenues Miss Estimates

    11:43 a.m. Aug. 3, 2022

    - Zacks.com

  3. Esperion stock rises as Q2 product revenue grows 28% Y/Y

    11:45 a.m. Aug. 2, 2022

    - Seeking Alpha

  4. 10-Q: ESPERION THERAPEUTICS, INC.

    8:53 a.m. Aug. 2, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  5. Esperion Therapeutics Q2 2022 Earnings Preview

    1:11 p.m. Aug. 1, 2022

    - Seeking Alpha

  6. Notable earnings before Tuesday's open

    10:59 a.m. Aug. 1, 2022

    - Seeking Alpha

  7. Loading more headlines...
/news/pressrelease/company/us/espr

Press Releases on ESPR

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.